 |
Alexza Pharmaceuticals, Inc.
(NASDAQ: ALXA)
Staccato™ System inhalation drug delivery platform to treat acute and intermittent medical conditions
http://www.alexza.com
|
Sector: Biopharma
Company Status: IPO
Investment Status: Current
|
 |
Alkermes, Inc.
(NASDAQ: ALKS)
Products for the treatment of diseases and disorders of the central nervous systems.
http://www.alkermes.com
|
Sector: Biopharma
Company Status: Public
Investment Status: Historical
|
 |
Amicus Therapeutics, Inc.
(NASDAQ: FOLD)
Oral pharmacological chaperone protein therapies to address diseases that result from protein misfolding
http://www.amicustherapeutics.com
|
Sector: Biopharma
Company Status: IPO
Investment Status: Current
NEA Board Members:
Mike Raab
|
 |
ANADYS Pharmaceuticals, Inc.
(NASDAQ: ANDS)
Small molecule medicines to treat infectious diseases, including hepatitis C and bacterial infections.
http://www.anadyspharma.com
|
Sector: Biopharma
Company Status: IPO
Investment Status: Historical
|
 |
Aradigm Corporation
(NASDAQ: ARDM)
AERx™ delivery system for pulmonary delivery of drugs for respiratory and systemic diseases
http://www.aradigm.com
|
Sector: Biopharma
Company Status: Public
Investment Status: Current
|
 |
Aronex Pharmaceuticals, Inc.
(NASDAQ: ARNX)
Proprietary pharmaceuticals for the treatment of cancer and life threatening conditions.
|
Sector: Biopharma
Company Status: Public
Investment Status: Historical
|
 |
Aurora Biosciences Corporation
(NASDAQ: ASBC)
Instrumentation and biological reagents for ultra high-throughput drug screening.
|
Sector: Biopharma
Company Status: IPO
Investment Status: Historical
|
| |
AutoImmune, Inc.
(NASDAQ: AIMM)
Pharmaceuticals to treat autoimmune diseases by inducing tolerance to autoantigens.
|
Sector: Biopharma
Company Status: IPO
Investment Status: Historical
|
 |
AXYS Pharmaceuticals, Inc.
(NASDAQ: AXPH)
Small molecule therapeutics through the integration of drug discovery techniques - from gene identification through clinical development.
|
Sector: Biopharma
Company Status: IPO
Investment Status: Historical
|
| |
Bethesda Research Laboratories
Products based on molecular biology.
|
Sector: Biopharma
Company Status: Private/Acquired by Life Technologies Inc.
Investment Status: Historical
|
